Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP
Status:
Recruiting
Trial end date:
2021-06-10
Target enrollment:
Participant gender:
Summary
The project was undertaking by Qilu Hospital of Shandong University in China. In order to
report the efficacy and safety of glycyrrhetinic acid combining with high-dose dexamethasone
for the treatment of adults with newly-diagnosed primary immune thrombocytopenia (ITP).